Paris, France, February 20, 2025 – EG 427, a biotechnology company leading the development of pinpoint genetic medicines for prevalent chronic diseases in neurology, announced today the successful ...

Lucy Solheim was diagnosed with myxopapillary ependymoma in July 2021. When cancer took away her hockey career, she found a way to take it back in the form of sled hockey.

Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted ...

Chimerix holds the potential to have the first approval of dordaviprone for treating recurrent H3 K27M mutant high-grade ...

The Abia State Commission for the Welfare of the Disabled Persons, has strengthened the capacity of leaders of persons with disabilities(PWDs), to respond to the needs of their cluster groups. The two ...

NRXBF READ THE FULL NRXBF RESEARCH REPORT NurExone (OTC:NRXBF) is developing a product known as ExoPTEN that is designed to treat patients with acute spinal cord injuries, while also conducting ...

Spinal muscle atrophyorspinal muscular atrophy(SMA) is a genetic disorder that can affect babies, children, and adults. A ...

From technology to the arts, sports and adventure and even space travel, these young Victorians are leading the charge in ...

For anyone in Louth who has ever dreamed of being part of a record-setting global event,  this is your chance. In less than ...

At 12 weeks, an unborn baby has developed a heart, spinal cord, toes, and limbs, according to the Mayo Clinic’s webpage about ...

Spinal muscular atrophy (SMA) is a progressive neurodegenerative disorder set in motion before birth. Scientists at St. Jude ...